共 45 条
- [1] Fisher B(1997)Effect of preoperative chemotherapy on local regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 2483-2493
- [2] Brown A(2017)Tumor biology predicts pathologic complete response to neoadjuvant chemotherapy in patients presenting with locally advanced breast cancer Ann Surg Oncol 34 3896-3902
- [3] Mamounas E(2012)Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla World J Surg 36 1453-1459
- [4] Lori F(2014)Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial Ann Surg 260 608-616
- [5] George P(2015)Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SNFNAC study J Clin Oncol 33 258-264
- [6] Emily C(2016)How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study[J] Ann Surg Oncol 23 3467-3474
- [7] Kumar A(2016)Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pretreatment positive axillary lymph nodes Ann Surg Oncol 23 1549-1553
- [8] Puri R(2014)Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial Ann Surg 260 608-616
- [9] Gadgil PV(2016)Biomarkers predicting pathological complete response to neoadjuvant chemotherapy in breast cancer Am J Clin Pathol 0 1-8
- [10] Boughey JC(2017)Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery JAMA 152 665-670